Literature DB >> 12046363

Use of warfarin during pregnancy.

Shirin Abadi1, Adrienne Einarson, Gideon Koren.   

Abstract

QUESTION: One of my patients, who has been taking warfarin for some time for treatment and prophylaxis of deep vein thrombosis, became pregnant due to failed contraception. I am unsure how to counsel her. Is there evidence that warfarin use during pregnancy is associated with fetal risk? ANSWER: If possible, warfarin therapy should be avoided during pregnancy. If warfarin therapy is essential, it should be avoided at least during the first trimester (because of teratogenicity) and from about 2 to 4 weeks before delivery to reduce risk of hemorrhagic complications. Unfractionated heparin or low molecular weight heparin could be substituted when appropriate because these agents do not cross the placenta and are considered the anticoagulant drugs of choice during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12046363      PMCID: PMC2214036     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  15 in total

1.  Pregnancy and its complications after cardiac valve replacement.

Authors:  A Ayhan; E G Yapar; K Yüce; H A Kişnişci; N Nazli; F Ozmen
Journal:  Int J Gynaecol Obstet       Date:  1991-06       Impact factor: 3.561

2.  Retrospective evaluation of the safety and efficacy of low-molecular-weight heparin as thromboprophylaxis during pregnancy.

Authors:  D M Schneider; G F von Tempelhoff; L Heilmann
Journal:  Am J Obstet Gynecol       Date:  1997-12       Impact factor: 8.661

Review 3.  Pregnancy in patients with mechanical prosthetic heart valves. Our experience regarding 98 pregnancies in 57 patients.

Authors:  E Vitali; F Donatelli; E Quaini; G Groppelli; A Pellegrini
Journal:  J Cardiovasc Surg (Torino)       Date:  1986 Mar-Apr       Impact factor: 1.888

4.  Anticoagulation during pregnancy.

Authors:  P I Pillans; E J Coetzee
Journal:  S Afr Med J       Date:  1986-04-12

5.  Warfarin embryopathy and urinary tract anomalies: possible new association.

Authors:  B D Hall
Journal:  Am J Med Genet       Date:  1989-10

6.  Pregnancy in patients with prosthetic heart valves: the effects of anticoagulation on mother, fetus, and neonate.

Authors:  D Born; E E Martinez; P A Almeida; D V Santos; A C Carvalho; A F Moron; C H Miyasaki; S D Moraes; J A Ambrose
Journal:  Am Heart J       Date:  1992-08       Impact factor: 4.749

7.  Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses.

Authors:  P Sareli; M J England; M R Berk; R H Marcus; M Epstein; J Driscoll; T Meyer; J McIntyre; C van Gelderen
Journal:  Am J Cardiol       Date:  1989-06-15       Impact factor: 2.778

8.  Combined use of warfarin and adjusted subcutaneous heparin during pregnancy in patients with an artificial heart valve.

Authors:  P K Lee; R Y Wang; J S Chow; K L Cheung; V C Wong; T K Chan
Journal:  J Am Coll Cardiol       Date:  1986-07       Impact factor: 24.094

9.  Outcome of pregnancy in women with valve prostheses.

Authors:  E Sbarouni; C M Oakley
Journal:  Br Heart J       Date:  1994-02

10.  The warfarin embryopathy: a rat model showing maxillonasal hypoplasia and other skeletal disturbances.

Authors:  A M Howe; W S Webster
Journal:  Teratology       Date:  1992-10
View more
  6 in total

Review 1.  Management of pregnancy in systemic lupus erythematosus.

Authors:  Aisha Lateef; Michelle Petri
Journal:  Nat Rev Rheumatol       Date:  2012-08-21       Impact factor: 20.543

Review 2.  Managing lupus patients during pregnancy.

Authors:  Aisha Lateef; Michelle Petri
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-06       Impact factor: 4.098

Review 3.  New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events.

Authors:  Ymer H Mekaj; Agon Y Mekaj; Shkelzen B Duci; Ermira I Miftari
Journal:  Ther Clin Risk Manag       Date:  2015-06-24       Impact factor: 2.423

4.  An evaluation of medication appropriateness in pregnant women with coexisting illness in a tertiary care hospital.

Authors:  Htet Wai Moe; Sushil Sharma; A K Sharma
Journal:  Perspect Clin Res       Date:  2019-12-20

Review 5.  Updates in Anticoagulation Therapy Monitoring.

Authors:  Hannah L McRae; Leah Militello; Majed A Refaai
Journal:  Biomedicines       Date:  2021-03-06

Review 6.  The Impact of Vitamin K2 (Menaquionones) in Children's Health and Diseases: A Review of the Literature.

Authors:  Agnieszka Kozioł-Kozakowska; Katarzyna Maresz
Journal:  Children (Basel)       Date:  2022-01-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.